Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to johnstevens77,Bhoddhisatva,scotia,Anonymous,Cornytiv34, for Donating to support the site

MrC's Smallcap Sweeps for Apr 2021

Discuss Stock buying Shares, tips and ideas for stock market dealing
MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

MrC's Smallcap Sweeps for Apr 2021

#400740

Postby MrContrarian » April 1st, 2021, 7:57 am

Smallcap Sweep. 01-Apr-21


Atlas Mara (ATMA) in principle agreement with the majority of its creditors on key commercial terms of the previously announced debt restructuring. Discussions continue with ABCH (who?) creditors. [SP=0.36 Cap=53m]
Supply @ME Capital (SYME) gross origination of Client companies up 13% from Dec to Mar. Progress has been made with Quadrivio Group and the Captive Bank acquisition process. [SP=0.58 Cap=194m]
Chamberlin (CMH) expects to publish delayed FY20 and H1 accounts mid Apr and immediate unsuspension. [SP=7.4 Cap=5m]
Infrastrata (INFA) rev c. £6.5m in last 8 months (FY20: £1.4m). Further growth momentum expected this year. Cash breakeven within the cruise and ferry market maintained. [SP=39 Cap=32m]
Gulf Marine Services (GMS) banks agree new debt terms as mooted. [SP=6.9 Cap=24m]
Braemar Shipping Services (BMS) completes mooted sale of Wavespec engineering div for £2.635m. [SP=200 Cap=63m]
Verditek (VDTK) recent imprevements to its solar panels means it needs new certification. Intergroup Mining order further delayed by component shortages. [SP=4.15 Cap=14m]
Pro Motion (PRO) recent float says its R-Amp process will leverage blockchain cloud knowledge to boost CBD sales. Also new LTIP could gift mgmt 24% if co if SP hits 104p. [SP=NA Cap=NA]
Thruvision (THRU) warns FY(Mar) rev only c. £6.7m. Blames zero sales in aviation mkt in H2 and weak customs mkt. Profit Protection market performed extremely well. [SP=23.69 Cap=34m]
Hemogenyx Pharmaceuticals (HEMO) negotiations have commenced with a global pharma co regarding the form of licensing and further development of CDX toward clinical trials. [SP=6.85 Cap=31m]
Galliford Try (GFRD) appointed to Scottish Water's new £700m Non-Infrastructure Framework for the SR21-27 investment programme, in a JV with MWH Treatment. The 50:50 joint venture, known as ESD, support the capital delivery functions of Scottish Water. [SP=127 Cap=141m]
1Spatial (SPA) wins multiyear contract with Defra to provide a managed service for Rural Payments Agency's Customer Portal and Land Management System. Potentially worth over £0.9m. [SP=46.85 Cap=52m]
Diaceutics (DXRX) secures a data licensing agreement with a global pharmaceutical company to provide COVID-19 testing data insights in the US. Details confidential but it does not change FY mgmt exp. [SP=102 Cap=86m]
Belvoir (BLV) buys White Kite Limited and Nicholas Humphreys Franchise Limited for £4m. Immediately earnings enhancing. [SP=200 Cap=70m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#401956

Postby MrContrarian » April 6th, 2021, 7:35 am

Smallcap Sweep. 06-Apr-21


Ilika (IKA) collaborating with Comau, part Fiat, to scale up Ilika's existing Goliath pre pilot line. £235k grant for design study. [SP=190.03 Cap=264m]
Oncimmune (ONC) agreements with Roche and Cedars-Sinai to profile patients using Oncimmune's novel Infectious Disease panel. SeroTag research panel has been tailored to predict COVID-19 disease severity and therapeutic response to the virus and the effectiveness of vaccines and other repurposed therapeutics as treatment against the disease. Both of these substantial new contracts will utilise this research tool to profile patient samples in search of immune related signatures in COVID-19 patients." [SP=190 Cap=131m]
Ethernity Networks (ENET) has started receiving production orders for its ENET Flow Processor FPGA systems-on-chip. Initial $400k for delivery early Q3. [SP=29.8 Cap=15m]
Argentex (AGFX) guides FY(Mar) rev down 3%, in line. [SP=127.5 Cap=145m]
NMCN (NMCN) new £12.5m overdraft. Also expects finance package to close this month/ [SP=265.55 Cap=28m]
Impact Healthcare (IHR) £50m placing at 111.5p, a 2.5% discount, to repay amounts drawn under its revolving credit facilities and to fund new investments. [SP=114.4 Cap=365m]
Avacta (AVCT) global distribution agreement with ABCAM o sell the Group's recently developed covid research ELISA Affimer reagents. "As far as we are aware, our spike protein ELISA test is the most sensitive test of its kind." [SP=233 Cap=590m]
Totally (TLY) wins contract extensions worth a total of c. £17.8m. [SP=30.25 Cap=55m]
SpaceandPeople (SAL) accident prone co extends Landsec contact to 2026. Covers 35 sites. [SP=9.5 Cap=2m]
Rosslyn Data Technologies (RDT) CEO resigns but will remain available to the board for transition .He is thanked. Chief Customer Officer becomes CEO. [SP=6.2 Cap=21m]
Q-AI (IQAI) Imaging Biometrics subsidiary wins (part of?) $3m grant to accelerate the development and commercialisation of IB CAD which uses AI to improve MRI. [SP=7.53 Cap=13m]
Zoetic (ZOE) UK Food Standards Agency allows its CBD products to remain on slae pending toxicological studies on CBD, expected in the coming months.. [SP=82.2 Cap=162m]

In line: RCN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#402177

Postby MrContrarian » April 7th, 2021, 7:43 am

Smallcap Sweep. 07-Apr-21


FireAngel Safety Technology (FA.) long term partnership with a German energy and efficiency service provider for the real estate sector to provide a fully funded R&D programme for a new generation smoke alarm. Fee of £1.4m for use of IP. Forecast 7m new devices, minimum of 3.5m in the first 2.5 years. Co thinks should earn up to €21m. [SP=14.22 Cap=18m]
CyanConnode (CYAN) gudes FY(Mar) rev 2.5x 15 months to Mar 2020, exceeding market expectation. [SP=6.8 Cap=13m]
Universe (UNG) 5 year contract extension with major O&G co for provision of loyalty services Europe-wide. Guides FY(Dec) in line but adj pretax ahead of expectations (whose?). [SP=4.86 Cap=13m]
HSS Hire (HSS) to sell its Irish large plant hire business for €11.2m. FY20 in line. Q1 EBITDA comfortably ahead YoY. [SP=20.2 Cap=141m]
Iomart (IOM) guides FY(Mar) at the lower end of expectations (whose?) due to lock down. Expectations not revised since Jan then? Rev £112m flat and adj pretax £20m (£22.8m). Cash ahead of the Board's expectations. [SP=321.5 Cap=352m]
finnCap (FCAP) guides FY(Mar) rev up 78% after strong March. [SP=31.1 Cap=54m]
VR Education (VRE) software platform ENGAGE 'strong traction' in Q1 with rev up up 138% on Q4. [SP=10 Cap=26m]
Synectics (SNX) wins multi-million-pound project from City of London Corporation and the City of London Police. Expected to be substantially delivered in 2021 + 5 years support. [SP=139.5 Cap=25m]
Arix Bioscience (ARIX) portfolio company, Artios Pharma starts collaboration with Novartis to create next generation DNA Damage Response cancer therapies. $20m up front + near term research funding. [SP=188.5 Cap=254m]

In line: GHH, IGP, VP., ADT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#402486

Postby MrContrarian » April 8th, 2021, 7:44 am

Smallcap Sweep. 08-Apr-21
Renalytix misleading RNS title

Equals (EQLS) FY(Dec) rev down 6% and adj EBITDA £1.2m, ahead of market expectations. Q1 2021 exceeded management expectations. [SP=39.5 Cap=71m]
Renalytix AI (RENX) Study shows that KidneyIntelX "may be widely adopted by primary care physicians". This somehow became 'highly likely' in the RNS title. [SP=930 Cap=897m]
Minds + Machine (MMX) to sell the majority of its assets for $120m adj for working capital. Implied value of approximately 10p/sh and 8.8p after costs and taxes. A review concluded "the business has strong recurring cash flows but expects limited opportunity for material organic growth beyond the Company's AdultBlock services without fundamental changes." GM to approve. [SP=4.5 Cap=40m]
Water Intelligence (WATR) has reacquired its Central Florida franchise for $0.66m (1x rev) "as it provides greater scale to corporate operations in eastern Florida, a geography with high demand for water infrastructure solutions". [SP=710 Cap=111m]
Spectra Systems (SPSY) will be granted US patent for its technology for disinfecting banknotes from SARS-2 and other biohazards. Patent applications have been filed in other regions. Uses nitrogen and heat. [SP=188.3 Cap=86m]
Lookers (LOOK) Q1 trading better than Board expectations with 44k (49k) vehicle sales. Guides FY(Dec) U/L pretax materially ahead of analyst consensus of £22.6m. [SP=62.6 Cap=244m]
Motorpoint (MOTR) guides FY(Mar) rev down 29%. H2 op profit broadly brake even. No fwd guidance. [SP=259 Cap=234m]
Alpha Financial Markets Consulting (AFM) guides FY(Mar) adj EBITDA toward the upper-end of the range of market expectations. [SP=261.8 Cap=267m]
Tavistock Investments (TAVI) guides FY(Mar) gross rev in advisory business and FuM flat. "The opportunistic approach made to the Company by TEAM plc, a newly listed AIM company supported by a small grouping of former employees and disaffected shareholders, has been an unwelcome distraction...Board has been exploring ways in which the inherent value of the Company's assets can be used to fund the Company's further development and to deliver significant value for shareholders." [SP=2.34 Cap=14m]
Cambridge Cognition (COG) wins £0.5m order with a new pharmaceutical client to provide cognitive assessments in an at-home clinical trial. [SP=100 Cap=31m]
Hyve (HYVE) guides H1(Mar) rev c. £10m, including rev from Groceryshop Spring Meetup (its first virtual Meetup event) which performed more than 10% ahead of expectations. £15.9m of further insurance claims approved. Co trading between tow scenarios. In both Hyve maintains its strong liquidity position [SP=130.1 Cap=345m]

In line: ALT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#402795

Postby MrContrarian » April 9th, 2021, 7:40 am

Smallcap Sweep. 09-Apr-21
Jam on radar for SRT. CEO scrapes it off with a knife

Gresham House Strategic (GHS) NAV at end March 1,515.4p/sh. [SP=1436.88 Cap=50m]
Versarien (VRS) £1.93m strategic investment at 45p (17% premium) by Graphene Lab, a South Korean based company specialising in chemical vapor deposition. Agreement to advance both Versarien's and Graphene Lab's proposed activities in South Korea. That Neill Ricketts is so persuasive. [SP=38.5 Cap=73m]
Wameja (WJA) Sunset Date for the Mastercard takeover extended to 24 May. No material change to the status of the Potential Indemnity Claims that are causing the holdup. [SP=5.8 Cap=110m]
Alpha Growth (ALGW) Black Oak Alpha Growth Fund AuM $25.5m. Co confident of strong growth prospects. [SP=3.53 Cap=15m]
Ramsdens (RFX) guides H1(Mar) 'resilient' with small loss but still cash positive. In line? [SP=172.5 Cap=54m]
FIH (FIH) guides FY(Mar) breakeven. Falkland Islands operations traded well. [SP=204 Cap=26m]
SRT Marine Systems (SRT) guides FY(Mar) rev c. £8.2m, pretax -£5.8m. Lockdowns resulted in no systems invoice milestones completed and no revenues recognised during the year. Expected Middle East orders delayed. "Four system opportunities in Asia worth approximately £50 million have developed more rapidly than expected and are now pending their contract processing." CEO "very sorry for this disappointment". Again. [SP=31.63 Cap=52m]
Star Phoenix (STA) to pursue arbitration proceedings re $10.2m bad debt. [SP=1.75 Cap=3m]
Good Energy (GOOD) further £1m strategic investment via a convertible loan note into Zap-Map, the UK's leading Electric Vehicle charging point mapping service. [SP=218 Cap=36m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#403514

Postby MrContrarian » April 12th, 2021, 7:40 am

Smallcap Sweep. 12-Apr-21


BATM Advanced Communication (BVC) Telco Systems subsidiary forms strategic partnership with albis-elcon, a supplier of networking products and systems, to jointly offer network function virtualisation. Also BATM has begun to generate revenue under its three-year licensing agreement with PCCW Global. [SP=97.1 Cap=428m]
Dev Clever (DEV) to buy Veative Labs Private Limited, an Indian subsidiary of Veative and buys the immersive education materials that will be utilised during the near-term roll-out of co's existing partnership agreement with Veative Labs. Pays £55m in paper, 20% of enlarged capital. [SP=36 Cap=214m]
GYG (GYG) will consult holders re approach from Harwood. [SP=87 Cap=41m]
Live Company (LVCG) guides FY(Dec) rev £1.9m. No substantial rev expected until Q3/Q4. Chmn says "My personal mission remains to steer the company back into profitability". Yeah, that is your job. [SP=5.4 Cap=6m]
InnovaDerma (IDP) expects to publish prospectus and circularre mooted fundraising later today. [SP=40.25 Cap=7m]
Cake Box (CBOX) guides H2(Mar) LFL up 15%, FY rev up 16% and adj pretax in line. [SP=252 Cap=102m]
C4X Discovery (C4XD) exclusive worldwide licensing agreement with Sanofi worth up to €414m, for oral pre-clinical IL-17A inhibitor programme. €7m upfront, rest is potential development, regulatory and commercialisation milestones plus royalties. Sanofi will develop and commercialise an oral therapy for the treatment of inflammatory diseases. [SP=39.63 Cap=91m]
Surface Transforms (SCE) FY(Dec) rev flat at £1.95m, pretax -£2.9m (-£3m). Outlook "when we go into production on OEM 8 and Aston Martin Valkyrie in 2021, at which point we will be profitable and generating cash from operations, before further capital investment." [SP=73 Cap=142m]
Xpediator (XPD) FY(Dec). Current Q1 ahead of management expectations. [SP=56.75 Cap=80m]

In line: BLV, INS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#403780

Postby MrContrarian » April 13th, 2021, 7:48 am

Smallcap Sweep. 13-Apr-21


Sosandar (SOS) guides FY(Mar) rev up 35%, EBITDA loss down over 60%. Q4(Mar) rev up 63%. March rev up 66% on Jan and 163% up on the lockdown impacted previous year. Net cash Net cash £3.93m, slightly up on Dec. [SP=19 Cap=37m]
Danakali (DNK) CFO scarpers. He is thanked. [SP=28.5 Cap=160m]
Open Orphan (ORPH) planning a possible spin-out of certain non-core Development IP Assets. [SP=45 Cap=301m]
GYG (GYG) a shipyard goes bust owing €2.8m. Co in discussions with the various parties involved with a view to agreeing a programme of works and payment schedule for completion of the contracts .Finals delayed. [SP=87.44 Cap=41m]
Dignity (DTY) activist holder Phoenix tweaking DTY's tail again but publishing proposals for value improvement. "Phoenix has made ill-advised public statements which have been self-serving and have had little regard for the wider interests of shareholders and other stakeholders." [SP=644 Cap=322m]
Circle Property (CRC) NAV/sh end March 277p dwn 6p in 6 months. [SP=213.92 Cap=61m]
Bion (BION) guides FY(Dec) rev up over 310%. Cites expansion of EPCC activities in Indonesia. [SP=2.7 Cap=12m]
Totally (TLY) guides FY(Mar) EBITDA substantially ahead of management expectations and YoY. Outlook: expects "significant growth for the insourcing division of the Group in the short term. The Group's Planned Care division has also resumed services during the past few months." [SP=30.7 Cap=56m]
SEEEN (SEEN) wins $50-200k contract with a major tire [sic] retailer. Q1 rev up 13% to $2.3m. Co will look to build further momentum through acquisitions. I still can't believe the stupid, gimmicky name. [SP=40 Cap=20m]
Mode Globa (MODE) Q1(Mar) Bitcoin trading volumes up 316%. This is the co that decided to 'invest' up to 10% of its cash reserves into Bitcoin. [SP=52.25 Cap=48m]
Quiz (QUIZ) guides FY(Mar) rev down 66% to £39.7m. Online down 42% which looks very poor. Net cash £1.5m. Does not expect termination of sales through Debenhams to materially impact profitability or cash flows. [SP=11 Cap=14m]
De La Rue (DLAR) guides FY(Mar) adj op profit around top end of £36-37m guidance. Net debt £53, £21m lower than market expectations. [SP=186.8 Cap=364m]
Hornby (HRN) guides FY(Mar) rev up 28%, ahead of budget. The tailwind has been huge so I'm not so impressed. [SP=49.6 Cap=83m]
Intelligent Ultrasound (IUG) gets CE approval of ScanNav Anatomy: Peripheral Nerve Block which helps with ultrasound local anaethesia. That's new to me. [SP=18 Cap=48m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#404091

Postby MrContrarian » April 14th, 2021, 7:50 am

Smallcap Sweep. 14-Apr-21
Will the Napster Phoenix sing or just die again?

Futura Medical PLC (FUM) FY. pinky potion prospects perky. [SP=55 Cap=137m]
Napster (NAPS) cuts spending on growth of the MelodyVR platform, "both application updates and new content streams will be limited during these coming months as resources are now focused on the development and subsequent relaunch of Napster." Convertible loan inc to 8m and drawdown accelerated. Also MelodyVR launches exclusive 5G partnership with NOS in Portugal which has 5m users. [SP=2.65 Cap=68m]
Mission (TMG) CFO scarpers. He is thanked. [SP=89.25 Cap=81m]
K3 Capital (K3C) guides FY(May) rev £45m and adj EBITDA at least £13.25m, significantly ahead of consensus upped in March. [SP=312 Cap=215m]
Palace Capital (PCA) trading. Rent collection continues to be 'very strong'. 82% of March 2021 Q rents collected or are expected to be received under monthly payment plans. Hudson Quarter enquiries and reservations on the residential units have increased significantly. Sells 2 properties for £2.45m, above book. [SP=232 Cap=107m]
Iconic Labs (ICON) Greencastle Acquisition bust up escalates with demand for £59k from Greencastle. ICON alledges serious wrongdoings by Greencastle which is run by former directors and others. [SP=0.01 Cap=3m]
Distil (DIS) guides FY(Mar) rev up 48% to £3.6m and volume up 30%. Adj EBITDA like-for-like up c.55% to £302k. LFL EBITDA? [SP=3.1 Cap=16m]
NewRiver (NRR) valuation decline in H2 will be less than that reported in H1. Is that supposed to be good? Has 'increasing optimism'. Will sell community pub business, probably by IPO. WIll sell non-core retail assets and recycle the resultant capital into resilient retail. Outlook "consumer economy will perform better than expected but that the retail sector will continue to be influenced by market trends which existed pre-COVID". [SP=103.4 Cap=317m]
Vianet (VNET) guides FY(Mar) adj op loss c. £0.7m and cash generation c £1.1m. In line? [SP=103 Cap=30m]
Audioboom (BOOM) Q1(Mar) rev up 49% and 12% on Q4. Adj EBITDA flat (-$0.5m). Guides FY (Dec) rev well ahead of market expectations. How long will the lockdown tailwind last? [SP=720 Cap=113m]
Foxtons (FOXT) Q1 strong with sales revenue up 60% and mortgage broking rev up 20%. CEO getting stick in press for taking £1m bonus while co took Gov't support. Shameless as ever. [SP=67 Cap=218m]

In line: RNO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#404390

Postby MrContrarian » April 15th, 2021, 7:39 am

Smallcap Sweep. 15-Apr-21

If you find my Smallcap Sweep useful click on https://melloevents.com/charity-pledge/ and consider donating some future profit to a worthwhile charity.
I've just made mine. Make yours!

600 (SIXH) guides FY(Mar) rev down 20%, EBIT c. $2.5m, above mgmt expectations. Orderbook up 70%, particularly strong in the higher margin side. [SP=8.55 Cap=10m]
Volex (VLX) guides FY(Apr) rev c. $440m and U/L operating profit at least $41m, ahead of the most recently guided range. Cites demand in the electric vehicle and consumer electronics markets. [SP=360.72 Cap=566m]
Iofina (IOF) Q1 record sales driven by strong market and backlog of deferred orders. Production down 17% though due to storms and extreme cold. [SP=12.3 Cap=24m]
Naked Wines (WINE) guides FY(Mar) rev up c. 68%, above 55-65% guidance. US rev hits 45% of total. [SP=805 Cap=589m]
React (REAT) guides H1(Mar) rev up c.19% organic and gross profit up c.43% organic. Cites strong underlying performance in the core business and some demand for COVID decontaminations. In line? [SP=2.4 Cap=3m]
Norcros (NXR) ups U/L profit guidance to £33m from £31m on rev down 5% (adj for 53 week FY last time). Net cash c. £10m (-£36.4m). [SP=288 Cap=233m]
1Spatial (SPA) Google contract extention of $500k, to be delivered in the current FY. [SP=40 Cap=44m]
Capital (CAPD) Q1 rev up 35% with "strongest demand environment for drilling services in a decade". [SP=64 Cap=122m]
Charles Stanley (CAY) Q4 FuM up 2%, rev down 1%, fee income rose 3.2% and commission income 1.5%, substantially offsetting lower interest rates. [SP=298.6 Cap=156m]
Epwin (EPWN) FY(Dec) rev down 15% and adj EPS 3.99p (10.29p). Trading - H2 2020 recovery has continued into 2021 with stronger than anticipated demand across most of the business. Looking at accelerating capex following the 'super deduction' announcement in the budget. [SP=97.76 Cap=142m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#404648

Postby MrContrarian » April 16th, 2021, 7:37 am

Smallcap Sweep. 16-Apr-21
Refreshing plain-speaking from Grafenia

Kainos (KNOS) guides FY(Mar) at the upper end of market consensus. [SP=1691 Cap=2076m]
Accsys Technologies (AXS) guides FY(Mar) volume up 4%, Accoya rev up 10% and 23% in H2. Margin up. In line? [SP=143 Cap=242m]
Zoetic (ZOE) a trading update with n rev figure. "By July 2021, it is expected that Chill products will be on sale in 3,500 high footfall outlets." New products coming. [SP=78.71 Cap=159m]
Infrastrata (INFA) wins £26m contract for fabrication and load-out of eight wind turbine generator jacket foundations. CEO trills "I believe that this contract paves the way for the execution and delivery of future fabrication contracts, a significant number of which are currently in advanced negotiations." [SP=42.15 Cap=34m]
Grafenia (GRA) guides FY(Mar rev down 39%. March rev down only 20%. Gross profit £5.6m (£8.0m). "However, we didn't get to where we wanted to be." A thoughtful and plain English strategy overview concludes "We will double down on the software part of Grafenia." End "The road to economic recovery looks a little hazy. Are those sunlit uplands? Or did someone start a fire in the top field?" [SP=5.5 Cap=6m]
Immunodiagnostic Systems (IDH) guides FY(rev) down 17%. H2 rev up 39% on H1. Outlook "The performance of the business during H2 FY21 was extremely positive as all key speciality revenue streams in our Automated Business unit returned to growth and the accelerated rate of placements of new analysers lays the foundation for future growth from recurring assay sales. We are now very confident that moving forward the revenue growth seen in this business unit pre-pandemic will continue, and most likely accelerate because the Vitamin D products which have historically depressed growth rates are a progressively less significant proportion of the product mix." [SP=183.96 Cap=53m]
Angle (AGL) wins first large-scale pharma services contract, for $1.2m, for Parsortix system monitoring in three separate global clinical trials. Potential for further contracts from the same customer. [SP=83 Cap=179m]
Yew Grove REIT (YEW) £10m placing at 95p, nil discount to LSE price for acquisition of assets. [SP=0.98 Cap=NA]
Chamberlin (CMH) long delayed FY(Mar20) and H1(Sep) results. Shares unsuspended. Outlook "market outlook is more positive, with all businesses enjoying sales levels above those of the prior year in recent months, excluding the effect of BorgWarner. Whilst the COVID 19 outlook in the UK is much brighter, things remain uncertain, particularly in Continental Europe where many of our customers are based. The substantial further restructuring mentioned above will reduce the overhead structure and the direct workforce to that needed for the reduced turnover caused by the BorgWarner contract termination. " [SP=7.4 Cap=5m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#405214

Postby MrContrarian » April 19th, 2021, 7:43 am

Smallcap Sweep. 19-Apr-21


Atlas Mara (ATMA) sells holdings in African Banking Corporation Botswanafor c. 1.13 times book, in line with the strategic review. [SP=0.36 Cap=52m]
Cambria Automobiles (CAMB) takeover deadline extended to 17 May. [SP=77 Cap=77m]
Yourgene Health (YGEN) awarded a gov't framework agreement for its covid assay and testing service. [SP=15 Cap=108m]
Genedrive (GDR) awarded a gov't framework agreement for its covid kits. [SP=67 Cap=42m]
Studio Retail (STU) end stategic review with sale of Findel Education for £30m gross. Also Q4 rev exceptionally strong with rev up 88% and gross margin up 650bps. Guides FY(Mar) adk pretax £48-50m, up 75% - 83%. [SP=290 Cap=252m]
Cerillion (CER) guides H1(Mar) rev up 25% and adj EBITDA c. £4.8m, above mgmt expectations. [SP=515 Cap=152m]
SysGroup (SYS) guies FY(Mar) rev down 7% but adj EBITDA up 3%, slightly ahead of market expectations. [SP=44 Cap=21m]
Maestrano (MNO) Q3 rev up 1% or down 6% in const currency. Total expenses up 46%. Some rev delayed to Q4 due to bad weather. [SP=18.5 Cap=31m]
D4t4 Solutions (D4T4) guides FY(Mar) rev £22.8m and adj pretax £4.2m, both ahead of mgmt expectations, comfortably so for adj pretax. [SP=324.89 Cap=131m]
Pelatro (PTRO) wins $500k contract. Total contracts for FY21 relivery c.$6.5m. [SP=37.95 Cap=14m]
Infrastrata (INFA) H!(Jan). Outlook "we see an immense amount of promise and a significant quantum of work becoming available...seeing a rejuvenation of business spend from both existing and new clients". [SP=48.23 Cap=39m]
Churchill China (CHH) FY(Dec) adj EPS 6.5 (81.7). No final div. Outlook "growing evidence from enquiries, order levels and sales that activity levels are recovering across our markets" [SP=1490 Cap=164m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#405508

Postby MrContrarian » April 20th, 2021, 7:41 am

Smallcap Sweep. 20-Apr-21


Brickability (BRCK) guides FY(Mar) rev c.£180m, adj EBITDA over £17m, ahead of previous expectations (whose?). Outlook co "fundamentally believes that the underlying demand for UK housing remains robust" 'Fundamentally believes'? [SP=86 Cap=198m]
i-nexus (INX) re SP rise and speculation regarding potential new contract awards: there have been no new material contract awards since Dec. That's not denying potential contracts. [SP=15.5 Cap=5m]
Avacta (AVCT) Clinical validation of AffiDX covid Antigen Lateral Flow Test: 98% sensitivity across a broad range of viral loads. [SP=236.32 Cap=599m]
Warpaint London (W7L) Q1 rev and gross margin up. Another 600 Tescos to stock product. W7 products are now being stocked in over 1,000 Five Below stores in the USA. [SP=108.9 Cap=84m]
City of London Investment Group (CLIG) FuM $11.1bn, up $0.1bn on Dec. [SP=526 Cap=267m]
Hargreaves Services (HSP) expects profit from German JV materially greater than current market expectations. Distribution & Services business and land business in line. Guides FY cash substantially higher than market expectations.. [SP=310 Cap=100m]
Zoo Digital (ZOO) guides FY(Mar) rev $39.5m (previous management guidance of at least $38m). Adj EBITDA c.$4.5m, over 100% up. Current trading strong. [SP=110.2 Cap=90m]
Franchise Brands (FRAN) Q1 adj EBITDA up 24%. Turnover returned to pre-COVID levels by the end of Q1. [SP=136 Cap=130m]
Crimson Tide (TIDE) three year agreement with the World Federation of Haemophilia, initially enable up to 100 clinicians to use mpro5 to scan pharmaceuticals. [SP=3.3 Cap=15m]
Urban Exposure (UEX) trims cash return range to 72 - 75p (72-78p). Considering share buy-backs, [SP=68 Cap=49m]
RBG Holdings (RBGP) FY. Also buys legal services provider for £30m, immediately and materially earnings enhancing. [SP=121.32 Cap=104m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#405761

Postby MrContrarian » April 21st, 2021, 7:38 am

Smallcap Sweep. 21-Apr-21


Inspiration Healthcare (IHC) SLE 6000 and OxyGenie approved for sale in China and orders of £250k. [SP=115 Cap=78m]
Fulcrum Utility Services (FCRM) two initial contracts, worth £5.9m over 2 years. Expects considerable opportunities for additional utility works on the development. [SP=36.65 Cap=81m]
System1 (SYS1) guides H2 rev up 8%, FY down 11%. Guides adj pretax (excluding loan int and bonuses!) £2.9m up 35%. Hiring staff. "We plan to remain profitable and to continue to generate cash but cost growth may exceed rev growth". [SP=199 Cap=25m]
Checkit (CKT) launches self-installation feature for automated temperature monitoring in the food industry, expected to provide a significant boost to competitive position. [SP=51.4 Cap=32m]
Spectra Systems (SPSY) extends central bank contract to detect "exotic counterfeits". Extra $1.2m of development funding to begin immediately. [SP=179 Cap=81m]
GSTechnologies (GST) MoU with Wise MPay with a view to enhancing its blockchain and new technology development capabilities. "In order to facilitate the Company's plans to focus on new higher growth synergistic business areas focussed on blockchain technology, particularly those applicable in the banking and wider financial services sector, the Company intends to jointly manage and contribute to the Coalculus blockchain platform." Blockchain and sysnergy! What's not to like? [SP=1.89 Cap=22m]
Diurnal (DNL) £20m placing and £2m OO at 70p, a 1.4% discount, for development and commercialisation. [SP=71.19 Cap=98m]

In line: DFCH, KIE, BIOM, NEXS, ATQT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#406016

Postby MrContrarian » April 22nd, 2021, 7:47 am

Smallcap Sweep. 22-Apr-21
Gear revs up

Solid State (SOLI) guides FY(Mar) ahead of recently upgraded consensus forecasts. Order book £41.3m (inc acquisitions) or £33.7m LFL (£39.9m) reflecting a continuation of shortened customer order cycles. [SP=842 Cap=72m]
Byotrol (BYOT) guides FY(Mar) broadly in-line with market expectations with rev over £11m and adj EBITDA over £1.7m (£6.1m and £0.3m respectively). Co remains highly confident in continued growth in the market, [SP=6.1 Cap=27m]
Time Finance (TIME) arrears below pre-pandemic levels and forbearance down 90% from June 2020 peak. [SP=27.99 Cap=25m]
Animalcare (ANCR) Daxocox (osteoarthritis-related breakthrough pain in dogs) approved for use by EU and UK. Co plans to launch Daxocox early in H2 into an initial addressable European market estimated to be in the region of £130m. [SP=274 Cap=165m]
Shearwater (SWG) guides FY(Mar) U/L EBITDA £3.6 (£3.4m), ahead of market expectations on rev down 4%. H2 rev up 24%. [SP=137 Cap=33m]
Bidstack (BIDS) AGM stmt: FY rev will continue to be significantly H" weighted. [SP=5.44 Cap=21m]
GETECH (GTC) licence renewals worth £375k. Also new ordes worth c.£350k. Confident FY in line. [SP=23 Cap=15m]
Ince (INCE) guides FY(Mar) rev up 1%. Outlook 'positive'. [SP=80 Cap=59m]
Spectra Systems (SPSY) wins $1m orders: Canadian lottery contract and renewal with a long term US lottery customer. [SP=182.2 Cap=83m]
Trifast (TRI) guides FY(Mar) ahead of market expectations of rev c.£175m and U/L pretax c.£11m (before IFRS2 changes). "Demand has returned to our traditional end markets and we are already actively working with new and existing customers across a number of new high growth markets, including Electric Vehicle & battery technology, 5G infrastructure and healthcare. The Group's return to sustained growth since September 2020, in addition to a very strong pipeline and high activity levels across all our key sectors, means we are looking ahead with confidence." [SP=161 Cap=219m]
Severfield (SFR) guides FY(Mar) comfortably above management expectations (no figus). Order book of £315m, "which supports trading throughout the 2022 financial year and beyond." [SP=77.8 Cap=240m]
Gear4music (G4M0 guides FY(Mar) rev up 31%, EBITDA £19m (£7.8m), ahead of market expectations. Outlook "leased with FY22 trading to date, relative to the exceptional period of trading during April 2020." [SP=NA Cap=NA]
Touchstar (TST) FY20 begins with the famous Mike Tyson quote "Everyone has a plan until they get hit", leaving out the crucial "...in the face". If you're a boxer of course you expect to get hit. Rev down 11.5%, above mgmt expectation. Prospects 'encouraging'. [SP=80.1 Cap=7m]

In line: OBOR
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#406411

Postby MrContrarian » April 23rd, 2021, 7:52 am

Smallcap Sweep. 23-Apr-21
Photo-Me guidance a picture

AEW UK REIT (AEWU) wins cases for unpaid rent totalling £602k. [SP=92 Cap=146m]
Supply @ME Capital (SYME) delays FY(Dec) accounts to May. [SP=0.42 Cap=124m]
Merit (MRIT) name change from Dods effective today. [SP=NA Cap=NA]
Bigblu Broadband (BBB) to sell holding in Quickline for up to £48.6m (84p/sh). £10.1m iscontingent and £5.6m loan notes. Price is up to 5.8x investment. Co will review the steps needed to return any surplus cash to shareholders within this FY and also consider investment opportunities. [SP=110 Cap=63m]
Fulham Shore (FUL) sales (without any inside seating) in the week ended Sunday ahead of same week two years ago. Planning expansion. [SP=16.18 Cap=100m]
Sealand Capital Galaxy (SCGL) wins contract worth HKD 2m (£186k). [SP=1.6 Cap=8m]
Photo-Me (PHTM) ups FY(Oct) guidance to rev of £190-200m (from £175m) and pretax (before exceptionals) £15-19m from £9m. [SP=65.6 Cap=248m]
Watchstone (WTG) plans move to Aquis exchange when suspended from AIM due to cash-shell rules. Co "intends to make further cash returns to shareholders as appropriate as its litigation assets are resolved and will continue to consider other commercial opportunities." [SP=52.34 Cap=24m]
e-Therapeutics (ETX) to receive two key milestone payments from Galapagos after meeting operational and success-based milestones. No £££. [SP=18.91 Cap=80m]
LSL Property Services (LSL) JV with Pollen Street Capital to create a new mortgage broker. LSL has committed up to £33.5m and PSC up to £62.4m to support acquisitions. [SP=336 Cap=353m]
Record (REC) Assets under management equivalents up 37% [SP=77.71 Cap=155m]
Audioboom (BOOM) guides FY rev significantly ahead of current market forecasts. No figs. [SP=660 Cap=104m]

In line: XPS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#406949

Postby MrContrarian » April 26th, 2021, 7:41 am

Smallcap Sweep. 26-Apr-21


Yourgene Health (YGEN) gets in to UK Framework for covid lab tests. [SP=14.09 Cap=100m]
React (REAT) wins 'material' 3 year contract to supply a full range of reactive cleaning and decontamination services to one of the world's leading facility management companies. Guides rev c. £2m+. [SP=2.52 Cap=3m]
Blackbird (BIRD) Blackbird video editing is being used by 18 more US TV stations for digital news production following TownNews' latest deployment [SP=24.25 Cap=82m]
Tristel (TSTL) guides FY(June) rev over £31m, comparable with last year. Guides pretax at least £5m. Medical device disinfectant sales in the UK still poor but surface disinfectant product sales have continued to gain market share. [SP=675 Cap=318m]
Staffline (STAF) guides FY(Dec) rev down 13% and U/L op profit c. £4.8m, ahead of expectations (whose?). Q1 trading ahead of management expectations. Board continues to evaluate its financing options. [SP=68.4 Cap=47m]
The Panoply (TPX) guides FY(Mar) rev up 62% and adj EBITDA at least 79% up, ahead of recently upgraded expectations. [SP=250 Cap=202m]
IXICO (IXI) guides H1(Mar) rev up 8% and adj order book £19m (£15.3m). [SP=82.5 Cap=40m]
Orchard Funding (ORCH) new bank facility from NatWest making total £22m. [SP=50.3 Cap=10m]
Seeing Machines (SEE) appointed by an additional global automotive Tier 1 supplier to deliver its FOVIO Driver and Occupant Monitoring System tech to an additional OEM. "Mass production is scheduled from late 2022 with an initial lifetime award value of A$7m." [SP=10.4 Cap=396m]
Induction Healthcare (INHC) wins contracts worth £440k total from 3 hospitals for Induction Zesty, "a digital front door for hospitals". [SP=103.95 Cap=44m]
Mind Gym (MIND) guides FY(Mar) rev down 18% cf previous guadance 20-30%. Adj pretax 0-£0.5m. CEO, Octavius Black, sounds like a Bond villain. [SP=135 Cap=130m]
Gyg (GYG) FY(Dec) results. Q1 2021 rev up 22% with some rev moved from Q4 into Q1 as previously reported. [SP=87.5 Cap=41m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#407281

Postby MrContrarian » April 27th, 2021, 7:39 am

Smallcap Sweep. 27-Apr-21
Abingdon Health sickly

LSL Property Services (LSL) contract to provide mortgage and protection advice to The Property Franchise Group's 430 estate agency offices. [SP=358 Cap=376m]
Abingdon Health (ABDX) warns FY(June) substantially below market expectations. Blames orders for covid rapid tests is taking longer than expected. Guides rev £11.4m to £17m and adj EBITDA -£3.3m to zero. No sign of Gov't paying £6.7m owed for tests. [SP=79.7 Cap=76m]
Water Intelligence (WATR) Q1 rev up 38% and pretax up 152%. Uses 'outstanding' four times. Outstanding! [SP=800 Cap=124m]
Immotion (IMMO) its flagship VR Theatre installation in Nevada has capacity limit raised from 50% to 80%. Nevada intends to allow 100% from June. [SP=6.18 Cap=26m]
Synectics (SNX) trading, as expected, carried on at similar levels to prev FY. Sees some early signs of increased customer activity in the gaming sector. [SP=138.5 Cap=25m]
Gaming Realms (GMR) FY(Dec). Recent trading marginally ahead of Board expectations. [SP=44.4 Cap=128m]
Chamberlin (CMH) CEO resigns, remains as director. New CEO chosen. [SP=8.35 Cap=6m]

In line: TRB, XAR, IHC
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#407539

Postby MrContrarian » April 28th, 2021, 7:45 am

Smallcap Sweep. 28-Apr-21


Frontier IP (FIPP) guides FY(June) materially ahead of management expectations with a significant contribution from increase in the value of Exscientia holding. [SP=74.1 Cap=41m]
IXICO (IXI) wins $0.5m contract to provide neuroimaging services for a new clinical trial for acute ischemic stroke. [SP=96.4 Cap=46m]
Mulberry (MUL) guides FY(Mar) small U/L pretax profit, ahead of previous guidance. Cites continued strong growth in the Group's Asian markets, strong sales on the Group's global digital platforms and improved margins due to lower mark-down sales. [SP=250 Cap=150m]
OKYO Pharma (OKYO) positive results of OK-201, a non-opioid analgesic drug candidate in an animal model. [SP=7.01 Cap=47m]
Beximco Pharmaceuticals (BXP) warns rev from distribution of covid vaccines in Bangladesh reduce this FY due to India restricting export. [SP=80 Cap=NA]
Metro Bank (MTRO) Q1 'solid'. [SP=115.5 Cap=199m]
Image Scan (IGE) H1(Mar) rev down 70%, pretax -£201k (+£180k). Guides FY in line. Wins order for 30 portable X-ray systems. [SP=2.94 Cap=4m]
HeiQ (HEIQ) FY(Dec) rev up 80%, pretax $7m ($1m). Jan trading guided FY above market expectations but didn't give figs. This Q1 in line. [SP=199 Cap=252m]
Warpaint London (W7L) FY(Dec) rev down 18%, in line. Ad EPS 3.1p (6.3p). This Q1 in line. [SP=127 Cap=97m]
French Connection (FCCN) FY(Jan) rev down 40%, U/L loss loss £11.7m (loss £2.9m). Net debt £1.3m (net funds: £8.1m). Outlook " wholesale business in both the UK and USA has bounced back for the Summer and Winter seasons...[UK stores] much better sales performance than we experienced at the end of the first national lockdown." Co is in formal sale process. [SP=22.5 Cap=22m]
1Spatial (SPA) FY(Jan) rev up 5%, pretax loss down 17%. Current trading in line. [SP=43.3 Cap=48m]
Brave Bison (BBSN) FY(Dec). Current trading in line. [SP=1.58 Cap=10m]

In line: TRAK, RPS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#407880

Postby MrContrarian » April 29th, 2021, 7:38 am

Smallcap Sweep. 29-Apr-21


InnovaDerma (IDP) confident about return of demand as UK enters 'peak tanning season'. I only use natural products ie sunshine. [SP=35 Cap=7m]
STV (STV) AGM stmt: January-April total advertising revenue +10%, ahead of previous guidance of +7-9%. "STV also expects a strong commercial and viewing performance in June as the economy continues to reopen, supported by a high-quality programme schedule." [SP=NA Cap=NA]
LMS Capital (LMS) NAV/sh 58.9p down 0.5p in the Q. [SP=32.98 Cap=27m]
Gaming Realms (GMR) upgrades from OTCQ Pink to OTCQX Best Market. This "will significantly enhance our visibility in the U.S. market". [SP=41 Cap=118m]
International Personal Finance (IPF) Q1 credit issued in-line with expectations but lower projected FY impairment charge likely to result in a stronger rebound in profitability than previously expected. [SP=121 Cap=271m]
In The Style (ITS) guides FY(Mar) rev up over 130%. New customers acquired up 19%. "The collaboration with Stacey Solomon is one that we are really proud of." Why? You just pay her to be your mouthpiece. [SP=249 Cap=131m]

In line: YGEN, DVO, APP
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Quarter
Posts: 1769
Joined: November 4th, 2016, 2:45 pm
Has thanked: 43 times
Been thanked: 1605 times

Re: MrC's Smallcap Sweeps for Apr 2021

#408249

Postby MrContrarian » April 30th, 2021, 7:44 am

Smallcap Sweep. 30-Apr-21


Synairgen (SNG) good result from combined data from the Hospital and Home Cohorts in inhaled interferon beta trial. "The study results reinforce confidence in ongoing Phase III study, with data readout on track for H2 2021." [SP=147.7 Cap=295m]
Restore (RST) £40m placing at 365p, a 5% discount, to fund £61m acquisition of EDM Group, a UK based information management company offering solutions to large and medium-sized enterprises. It's immediately accretive to underlying EPS. [SP=385 Cap=484m]
Sensyne Health (SENS) 5 year non-exclusive Strategic Research Agreement with an NHS Foundation Trust. "The agreement will enable the ethical application of clinical AI research to improve patient care and accelerate research into new medicines." The Trust will get 0.87% of share cap. [SP=165 Cap=272m]
Driver (DRV) guides H1(Mar) pretax (before share based payment charges) down only slightly. Outlook encouraging. "Meaningful progress has already been made in implementing the five year strategic plan." [SP=56 Cap=29m]
Omega Diagnostics (ODX) launches rapid covid test. Talking to distributors. Waiting for confirmation on which test has successfully passed Govt performance evaluations. "Once a suitable test has been approved the DHSC will license the test for Omega to manufacture." [SP=73.5 Cap=134m]
Futura Medical (FUM) gets EU Quality Management Certificate for erectile disfunction gel. [Insert your own double-entendre here]. [SP=45 Cap=115m]
Headlam (HEAD) sells Swiss floorcoverings distribution business for c. £12m. [SP=462 Cap=393m]
Genedrive (GDR) covid lab test approved in India. Price is controlled but co "believes however that formal performance evaluation data and ICMR approval will contribute positively to commercial efforts and premium products such as gendrive's can play a part in the need for COVID-19 testing." [SP=72.5 Cap=46m]
Card Factory (CARD) performance following reopening has exceeded its expectations. Also agrees refinancing. Covenant waivers extended. [SP=78.5 Cap=268m]
Westminster Group (WSG) FY20 in line. Guides FY21 in line. [SP=4.1 Cap=12m]
UP Global Sourcing (UPGS) H1 rev up 11%. Guides FY rev over £135m and U/L pretax over £10.8m, ahead of current expectations. [SP=158.33 Cap=130m]
Arix Bioscience (ARIX) Outcome of Strategic Implementation Review: director changes and "the Board now has a clear understanding of shareholder views, enabling it to implement its strategy more effectively." Is that it? [SP=189 Cap=252m]
FireAngel (FA.) £2.9m placing and £6.9m OO at 18p, a 20% discount, for R&D and efficiency improvements. [SP=22.3 Cap=28m]
H&T (HAT) CFO leaves to pursue a project outside the group. He is thanked. [SP=289.5 Cap=115m]
PCI-PAL (PCIP) £5.5m placing at 95p, a 9% discount, to fund overseas expansion. [SP=104.18 Cap=62m]

In line: ELCO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian


Return to “Stocks and Share Dealing Discussions”

Who is online

Users browsing this forum: No registered users and 7 guests